Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q4 2023 ▲▼ | Q1 2024 ▲▼ | Change ▲▼ | Q4 2023 ▲▼ | Q1 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Merck & Co., Inc.(MRK) | 65,675 | 133,741 | +68,066 | $7.16M | $17.65M | 10.74% | +$10.49M |
| Eli Lilly and Company(LLY) | 15,805 | 20,778 | +4,973 | $9.21M | $16.16M | 9.84% | +$6.95M |
| UnitedHealth Group Incorporated(UNH) | 18,408 | 23,041 | +4,633 | $9.69M | $11.40M | 6.94% | +$1.71M |
| Thermo Fisher Scientific Inc.(TMO) | 11,415 | 15,186 | +3,771 | $6.06M | $8.83M | 5.37% | +$2.77M |
| Neurocrine Biosciences, Inc.(NBIX) | 12,617 | 43,480 | +30,863 | $1.66M | $6.00M | 3.65% | +$4.33M |
| Harmony Biosciences Holdings, Inc.(HRMY) | 145,000 | 170,000 | +25,000 | $4.68M | $5.71M | 3.47% | +$1.03M |
| Stryker Corporation(SYK) | 12,802 | 15,154 | +2,352 | $3.83M | $5.42M | 3.30% | +$1.59M |
| Amgen Inc.(AMGN) | 16,023 | 18,891 | +2,868 | $4.61M | $5.37M | 3.27% | +$756.1K |
| AbbVie Inc.(ABBV) | 21,196 | 29,346 | +8,150 | $3.28M | $5.34M | 3.25% | +$2.06M |
| Boston Scientific Corporation(BSX) | 64,806 | 77,401 | +12,595 | $3.75M | $5.30M | 3.23% | +$1.55M |
| Regeneron Pharmaceuticals, Inc.(REGN) | 3,979 | 5,393 | +1,414 | $3.49M | $5.19M | 3.16% | +$1.70M |
| Cencora Inc | 38,925 | 20,426 | -18,499 | $7.99M | $4.96M | 3.02% | -$3.03M |
| Molina Healthcare, Inc.(MOH) | 12,500 | 12,000 | -500 | $4.52M | $4.93M | 3.00% | +$413.6K |
| Vertex Pharmaceuticals Incorporated(VRTX) | 9,130 | 11,295 | +2,165 | $3.71M | $4.72M | 2.87% | +$1.01M |
| Option Care Health, Inc.(OPCH) | 37,223 | 132,895 | +95,672 | $1.25M | $4.46M | 2.71% | +$3.20M |
| Elevance Health, Inc.(ELV) | 9,500 | 7,400 | -2,100 | $4.48M | $3.84M | 2.33% | -$642.6K |
| Gilead Sciences, Inc.(GILD) | 98,974 | 52,000 | -46,974 | $8.02M | $3.81M | 2.32% | -$4.21M |
| DexCom, Inc.(DXCM) | 18,057 | 26,283 | +8,226 | $2.24M | $3.65M | 2.22% | +$1.40M |
| Mirum Pharmaceuticals, Inc.(MIRM) | 0 | 123,000 | +123,000 | $0 | $3.09M | 1.88% | +$3.09M |
| Cardinal Health, Inc.(CAH) | 48,000 | 27,500 | -20,500 | $4.84M | $3.08M | 1.87% | -$1.76M |
| Amicus Therapeutics Inc COM | 48,710 | 252,307 | +203,597 | $691.2K | $2.97M | 1.81% | +$2.28M |
| Fusion Pharmaceuticals Inc | 125,000 | 138,836 | +13,836 | $1.20M | $2.96M | 1.80% | +$1.76M |
| Ionis Pharmaceuticals, Inc.(IONS) | 24,243 | 63,791 | +39,548 | $1.23M | $2.77M | 1.68% | +$1.54M |
| Immunocore Holdings plcADS(IMCR) | 7,823 | 40,899 | +33,076 | $534.5K | $2.66M | 1.62% | +$2.12M |
| Intra-Cellular Therapies Inc | 12,245 | 38,050 | +25,805 | $877.0K | $2.63M | 1.60% | +$1.76M |
| IQVIA Holdings Inc.(IQV) | 10,340 | 10,058 | -282 | $2.39M | $2.54M | 1.55% | +$151.1K |
| Edwards Lifesciences Corp | 20,815 | 24,775 | +3,960 | $1.59M | $2.37M | 1.44% | +$780.4K |
| Shockwave Med Inc | 3,530 | 4,751 | +1,221 | $672.7K | $1.55M | 0.94% | +$874.4K |
| Corbus Pharmaceuticals Holdings, Inc.(CRBP) | 0 | 38,000 | +38,000 | $0 | $1.49M | 0.91% | +$1.49M |
| Cabaletta Bio, Inc.(CABA) | 21,000 | 77,540 | +56,540 | $476.7K | $1.32M | 0.80% | +$846.1K |
| Arcellx Inc COMMON STOCK | 11,400 | 17,496 | +6,096 | $632.7K | $1.22M | 0.74% | +$584.1K |
| Krystal Biotech, Inc.(KRYS) | 6,624 | 6,624 | 0 | $821.8K | $1.18M | 0.72% | +$356.8K |
| BridgeBio Pharma, Inc.(BBIO) | 23,985 | 37,841 | +13,856 | $968.3K | $1.17M | 0.71% | +$201.8K |
| Endeavour Silver Corp.(EXK) | 12,157 | 16,120 | +3,963 | $899.4K | $1.11M | 0.68% | +$213.9K |
| Merus N V | 24,325 | 24,325 | 0 | $668.9K | $1.10M | 0.67% | +$426.4K |
| Inspire Medical Systems, Inc.(INSP) | 3,229 | 4,782 | +1,553 | $656.9K | $1.03M | 0.62% | +$370.3K |
| Cytokinetics, Incorporated(CYTK) | 11,733 | 14,000 | +2,267 | $979.6K | $981.5K | 0.60% | +$2.0K |
| Madrigal Pharmaceuticals, Inc.(MDGL) | 2,531 | 3,539 | +1,008 | $585.6K | $945.1K | 0.58% | +$359.4K |
| MacroGenics, Inc.(MGNX) | 0 | 49,307 | +49,307 | $0 | $725.8K | 0.44% | +$725.8K |
| Akero Therapeutics Inc | 15,432 | 24,432 | +9,000 | $360.3K | $617.2K | 0.38% | +$256.8K |
| Autolus Therapeutics plcADS(AUTL) | 96,345 | 96,345 | 0 | $620.5K | $614.7K | 0.37% | -$5.8K |
| Newamsterdam Pharma Company ORDINARY SHARES | 0 | 22,394 | +22,394 | $0 | $529.6K | 0.32% | +$529.6K |
| Morphic Hldg Inc | 14,952 | 14,952 | 0 | $431.8K | $526.3K | 0.32% | +$94.5K |
| Mersana Therapeutics Inc | 0 | 100,000 | +100,000 | $0 | $448.0K | 0.27% | +$448.0K |
| Ambrx Biopharma Inc | 57,847 | 0 | -57,847 | $823.7K | $0 | — | -$823.7K |
| Bristol-Myers Squibb Company(BMY) | 88,000 | 0 | -88,000 | $4.52M | $0 | — | -$4.52M |
| Centene Corporation(CNC) | 62,000 | 0 | -62,000 | $4.60M | $0 | — | -$4.60M |
| Pfizer Inc.(PFE) | 42,820 | 0 | -42,820 | $1.23M | $0 | — | -$1.23M |
| Prothena Corp PlcSHS SHS | 8,342 | 0 | -8,342 | $303.1K | $0 | — | -$303.1K |
| The Cigna Group(CI) | 15,000 | 0 | -15,000 | $4.49M | $0 | — | -$4.49M |